{
  "pmid": "32815780",
  "uid": "32815780",
  "title": "Evaluating the FDA regenerative medicine framework: opportunities for stakeholders.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Richardson",
      "fore_name": "Elizabeth",
      "initials": "E",
      "name": "Elizabeth Richardson",
      "affiliations": [
        "Director, Health Care Products Project, The Pew Charitable Trusts, 901 E Street, NW, Washington, DC 20004-2008, USA."
      ]
    },
    {
      "last_name": "Akkas",
      "fore_name": "Farzana",
      "initials": "F",
      "name": "Farzana Akkas",
      "affiliations": [
        "Senior Research Associate, Health Care Products Project, The Pew Charitable Trusts, 901 E Street, NW, Washington, DC 20004-2008, USA."
      ]
    },
    {
      "last_name": "Master",
      "fore_name": "Zubin",
      "initials": "Z",
      "name": "Zubin Master",
      "affiliations": [
        "Associate Professor, Biomedical Ethics Research Program & Center for Regenerative Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA."
      ],
      "orcid": "0000-0002-3462-4546"
    }
  ],
  "journal": {
    "title": "Regenerative medicine",
    "iso_abbreviation": "Regen Med",
    "issn": "1746-076X",
    "issn_type": "Electronic",
    "volume": "15",
    "issue": "7",
    "pub_year": "2020",
    "pub_month": "Jul"
  },
  "start_page": "1825",
  "end_page": "1832",
  "pages": "1825-1832",
  "language": "eng",
  "publication_types": [
    "Editorial"
  ],
  "keywords": [
    "Humans",
    "Regenerative Medicine",
    "Stem Cell Transplantation",
    "United States",
    "United States Food and Drug Administration"
  ],
  "article_ids": {
    "pubmed": "32815780",
    "doi": "10.2217/rme-2020-0073"
  },
  "doi": "10.2217/rme-2020-0073",
  "dates": {
    "completed": "2021-08-23",
    "revised": "2021-08-23"
  },
  "chemicals": [],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:53:59.398981",
    "pmid": "32815780"
  }
}